146 related articles for article (PubMed ID: 30456681)
1. Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
Bertolli E; Franke V; Calsavara VF; de Macedo MP; Pinto CAL; van Houdt WJ; Wouters MWJM; Duprat Neto JP; van Akkooi ACJ
Ann Surg Oncol; 2019 Feb; 26(2):395-405. PubMed ID: 30456681
[TBL] [Abstract][Full Text] [Related]
2. A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.
Damude S; Wevers KP; Murali R; Kruijff S; Hoekstra HJ; Bastiaannet E
Eur J Surg Oncol; 2017 Sep; 43(9):1753-1759. PubMed ID: 28797756
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR; Mocellin S; Campana LG; Borgognoni L; Sestini S; Giudice G; Caracò C; Cordova A; Solari N; Piazzalunga D; Carcoforo P; Quaglino P; Caliendo V; Ribero S;
Ann Surg Oncol; 2018 Jan; 25(1):271-279. PubMed ID: 29067603
[TBL] [Abstract][Full Text] [Related]
5. Performance of models predicting residual lymph node disease in melanoma patients following sentinel lymph node biopsy.
MacDonald S; Siever J; Baliski C
Am J Surg; 2020 May; 219(5):750-755. PubMed ID: 32222274
[TBL] [Abstract][Full Text] [Related]
6. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
[TBL] [Abstract][Full Text] [Related]
7. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
[TBL] [Abstract][Full Text] [Related]
8. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
9. Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients.
Bertolli E; Macedo MP; Pinto CA; Damascena AS; Molina AS; Duprat Neto JP
Melanoma Res; 2016 Feb; 26(1):42-5. PubMed ID: 26397049
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
[TBL] [Abstract][Full Text] [Related]
12. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
Woods JF; De Marchi JA; Lowery AJ; Hill AD
Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
[TBL] [Abstract][Full Text] [Related]
13. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
[TBL] [Abstract][Full Text] [Related]
14. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma.
Verwer N; Scolyer RA; Uren RF; Winstanley J; Brown PT; de Wilt JH; Thompson JF
Ann Surg Oncol; 2011 Nov; 18(12):3292-9. PubMed ID: 21913021
[TBL] [Abstract][Full Text] [Related]
16. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
Bertolli E; de Macedo MP; Calsavara VF; Pinto CAL; Duprat Neto JP
J Am Acad Dermatol; 2019 Mar; 80(3):722-726. PubMed ID: 30395920
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma.
Bertolli E; Calsavara VF; de Macedo MP; Pinto CAL; Duprat Neto JP
Tumori; 2021 Oct; 107(5):440-445. PubMed ID: 33143554
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
20. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
